Regeneron plans to buy 23andMe for $256M
23andMe has found a buyer.
Regeneron will buy the struggling 23andMe through its court-supervised sale for $256 million, the companies disclosed Monday morning.
The move …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.